Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the nidus of Aβ plaques develops from within neurites at a time course that could also fit that of plaque formation determined by multiphoton microscopy (MPM) occurring within a day [120].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the AD brain, microglia accumulate at the site of newly formed A deposits via migration or local proliferation and may help restrict plaque growth.4,5”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brains of AD patients and APP-overexpressing mice, plaques are surrounded by reactive microglia and astrocytes (Meyer-Luehmann et al., 2008; Serrano-Pozo et al., 2013)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Meyer-Luehmann et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia appear rapidly (within one day) at the site of newly formed plaques [78].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“Remarkably, this MPM study of AD transgenic mouse brain in vivo also described the emergence of dystrophic neurites in areas distant from plaques that appeared and, at times, even disappeared, although intraneuronal Aβ was not examined in these neurites.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 2×
“These data thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid deposition, activation and recruitment of microglia and local neuritic changes play out as a sequential cascade leading to neurodegeneration 1 .”
BackgroundResultWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“To examine whether the phenotype of plaque formation in as short a period as one week was unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a slower progression of disease (Tg2576) 7 .”
BackgroundMethodImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In addition, homozygous PDAPP mice 16 were crossed with homozygous CX3CR1-GFP mice 17 , and two female PDAPP +/ − ×CX3CR1-GFP +/ − transgenic mice at the age of 18 months were used in this study and imaged for three consecutive days.”
BackgroundMethodJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 1×
“These results are surprising because it has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process 22 .”
ResultJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“It has been proposed that activated microglia clear amyloid deposits 13 , are the nidus for initiation of amyloid fibrils 14 or restrict plaques 15 .”
Background
Cited by
Items 301–400 of 995
Single-Molecule Atomic Force Microscopy Force Spectroscopy Study of Aβ-40 Interactions
Kim, B., Palermo, N. Y., Lovas, S., Zaikova, T. O., Keana, J. F. W., & Lyubchenko, Y. L. (2011) · Biochemistry · doi:10.1021/bi200147a · Cited by 96
Allsop, D., Mayes, J., Moore, S., Masad, A., & Tabner, B. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361293 · Cited by 85
The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 85
Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice
Ni, R., Chen, Z., Deán‐Ben, X. L., Voigt, F. F., Kirschenbaum, D. S., Shi, G., Villois, A., Zhou, Q., Crimi, A., Arosio, P., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00906-1 · Cited by 91
Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns
Hwang, J., Kim, C. M., Jeon, S., Lee, J. M., Hong, Y. J., Roh, J. H., Lee, J., Koh, J., Na, D. L., & Initiative, A. D. N. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.008 · Cited by 84
“Many experimental and clinical studies have demonstrated that Ab accumulation precedes tau-mediated neuronal injury and glucose hypometabolism [24,34,35].”
BackgroundKell, D. B., & Pretorius, E. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.08.006 · Cited by 96
Alzheimer's disease: a mathematical model for onset and progression
Bertsch, M., Franchi, B., Marcello, N., Tesi, M. C., & Tosin, A. (2017) · PORTO Publications Open Repository TOrino (Politecnico di Torino) · Cited by 87
The Evolving Biology of Microglia in Alzheimer's Disease
Malm, T. M., Jay, T. R., & Landreth, G. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0316-8 · Cited by 85
Senescent Microglia: The Key to the Ageing Brain?
Greenwood, E. K., & Brown, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094402 · Cited by 84
“In addition, a loss of phagocytic ability, which is known to be a feature of senescent or aged cells, has been implicated in the diminished capacity of the brain for clearance of Amyloid β (Aβ) [75,95,115,155], paving the way for formation of amyloid plaques and their spread throughout the brain.”
BackgroundPirzada, R. H., Javaid, N., & Choi, S. (2020) · Genes · doi:10.3390/genes11020131 · Cited by 88
“The recruitment of microglia in AD is due to the secretion of neurotoxic components produced by senile neurofibrillary plaques [133]; these cells then phagocytose Aβ deposits and further secrete proinflammatory and chemotactic cytokines to aggravate the neurotoxic effects of Aβ.”
BackgroundGaikwad, S. M., Larionov, S., Wang, Y., Dannenberg, H., Matozaki, T., Monsonego, A., Thal, D. R., & Neumann, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090147 · Cited by 88
Network-wide dysregulation of calcium homeostasis in Alzheimer’s disease
Brawek, B., & Garaschuk, O. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1798-8 · Cited by 89
Two-Photon Microscopy for Chemical Neuroscience
Ellis‐Davies, G. C. R. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn100111a · Cited by 92
Wu, J., Shao, C., Ye, X., Di, X., Li, D., Zhao, H., Zhang, B., Chen, G., Liu, H., & Qian, Y. (2021) · ACS Sensors · doi:10.1021/acssensors.0c01914 · Cited by 80
Independent component analysis of Alzheimer's DNA microarray gene expression data
Kong, W., Mou, X., Liu, Q., Chen, Z., Vanderburg, C. R., Rogers, J. T., & Huang, X. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-5 · Cited by 82
“In fact, even though recent studies have indicated that certain aspects of the inflammatory response may have therapeutic potential [22-24], neuroinflammation is commonly believed to be a culprit in AD pathogenesis.”
BackgroundDao, P., Ye, F., Liu, Y., Du, Z. Y., Zhang, K., Dong, C. Z., Meunier, B., & Chen, H. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00380 · Cited by 80
Microglia and Synapse: Interactions in Health and Neurodegeneration
Šišková, Z., & Tremblay, M.-È. (2013) · Neural Plasticity · doi:10.1155/2013/425845 · Cited by 80
“In vivo imaging showed that Aβ plaques can form surprisingly quickly (over 24 hours) and microglia might help to restrict their growth [53].”
Microglia transcriptional states and their functional significance: Context drives diversity
Depp, C., Doman, J. L., Hingerl, M., Xia, J., & Stevens, B. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.009 · Cited by 101
Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice
Buskila, Y., Crowe, S. E., & Ellis-Davies, G. C. R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.016 · Cited by 77
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
“In a very elegant in vivo imaging study, Meyer-Luehmann et al. (2008) demonstrated that in PDAPP mice expressing the enhanced green fluorescent protein (EGFP) in microglia, extremely fast 24-hour plaque formation led to immediate microglial recruitment around plaques.”
Islam, R., Zaman, A., Jahan, I., Chakravorty, R., & Chakraborty, S. (2013) · Journal of Young Pharmacists · doi:10.1016/j.jyp.2013.11.005 · Cited by 82
Microglia as a critical player in both developmental and late-life CNS pathologies
Derecki, N. C., Katzmarski, N., Kipnis, J., & Meyer-Luehmann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1321-z · Cited by 78
“1 3 towards newly formed plaques [83], suggesting that they might transform into a hypertrophic or even amoeboid cell type in response to Aβ plaque formation and could have a pathological role.”
BackgroundSelf-citationAmyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Pradeepkiran, J. A., Baig, J., Islam, M. A., Kshirsagar, S., & Reddy, P. H. (2024) · Aging and Disease · doi:10.14336/ad.2024.0286 · Cited by 102
Sequestration of the Aβ Peptide Prevents Toxicity and Promotes Degradation In Vivo
Luheshi, L. M., Hoyer, W., de Barros, T. P., van Dijk Härd, I., Brorsson, A.-C., Macao, B., Persson, C., Crowther, D. C., Lomas, D. A., Ståhl, S., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000334 · Cited by 78
“changes [7], and there is a quantitative correlation between the propensities of mutant forms of Ab to aggregate and their neurotoxicity [8].”
Eisele, Y. S., & Duyckaerts, C. J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1516-y · Cited by 89
Veloso, A. J., Chow, A. M., Ganesh, H. V. S., Li, N., Dhar, D., Wu, D. C. H., Mikhaylichenko, S. N., Brown, I. R., & Kerman, K. (2014) · Analytical Chemistry · doi:10.1021/ac500424t · Cited by 89
Kim, H. J., Ajit, D., Peterson, T. S., Wang, Y., Camden, J. M., Gibson Wood, W., Sun, G. Y., Erb, L., Petris, M., & Weisman, G. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07700.x · Cited by 77
Isolated Amyloid-β(1–42) Protofibrils, But Not Isolated Fibrils, Are Robust Stimulators of Microglia
Paranjape, G. S., Gouwens, L. K., Osborn, D. C., & Nichols, M. R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn2001238 · Cited by 77
Complementing the inflammasome
Triantafilou, M., Hughes, T. R., Morgan, B. P., & Triantafilou, K. (2016) · Immunology · doi:10.1111/imm.12556 · Cited by 76
Immune Activation in Alzheimer Disease
Mary, A., Mancuso, R., & Heneka, M. T. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-035222 · Cited by 85
Sharma, B., Satija, G., Madan, A., Garg, M., Alam, M. M., Shaquiquzzaman, M., Khanna, S., Tiwari, P., Parvez, S., Iqubal, A., et al. (2023) · Inflammation · doi:10.1007/s10753-022-01730-0 · Cited by 75
“NLRP3 is a critical pattern recognition receptor involved in the expression of immune responses and has been found to play a significant role in the development of various immunological and neurological disorders such as multiple sclerosis, ulcerative colitis, gout, diabetes, and AD [9, 10].”
BackgroundCameron, B., Tse, W., Lamb, R., Li, X., Lamb, B. T., & Landreth, G. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1729-12.2012 · Cited by 73
“Furthermore, plaque formation is associated with dysmorphic neurites (Hickman et al., 2008; Meyer-Luehmann et al., 2008).”
BackgroundInfluentialPassive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease
Spires-Jones, T. L., Mielke, M. L., Rozkalne, A., Meyer-Luehmann, M., de Calignon, A., Bacskai, B. J., Schenk, D., & Hyman, B. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.011 · Cited by 74
Self-citationα-Synuclein Misfolding: Single Molecule AFM Force Spectroscopy Study
Yu, J., Málková, Š., & Lyubchenko, Y. L. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.006 · Cited by 84
Vashist, S., Cushman-Nick, M., & Shorter, J. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-121 · Cited by 87
Michno, W., Nyström, S., Wehrli, P., Lashley, T., Brinkmalm, G., Guerard, L., Syvänen, S., Sehlin, D., Kaya, I., Brinet, D., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006604 · Cited by 75
“In contrast, independent mechanisms for cored plaque formation have been suggested based on experiments in different transgenics, where cored plaques are also observed in younger mice (31, 46, 47).”
BackgroundVitamin D receptor 2016: novel ligands and structural insights
Maestro, M. A., Molnár, F., Mouriño, A., & Carlberg, C. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1216547 · Cited by 81
“nuclear receptor farnesoid X receptor [23].”
Upadhaya, A. R., Lungrin, I., Yamaguchi, H., Fändrich, M., & Thal, D. R. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01306.x · Cited by 74
“in areas with high levels of hiMWA presumably dissolved from A plaques, in the APP transgenic mouse brain [7, 8, 29], in aged rhesus monkeys [30] and in the AD brain [31], and also by the finding that dendritic degeneration in another APP-transgenic mouse model begins at the same time as the deposition of initial diff…”
BackgroundMicroglial calcium signaling in the adult, aged and diseased brain
Brawek, B., & Garaschuk, O. (2013) · Cell Calcium · doi:10.1016/j.ceca.2012.12.003 · Cited by 78
Amyloid precursor protein-induced axonopathies are independent of amyloid-β peptides
Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., Lillo, C., Mount, S. L., Roberts, E. A., McGowan, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn240 · Cited by 78
Garcia-Alloza, M., Subramanian, M., Thyssen, D., Borrelli, L. A., Fauq, A., Das, P., Golde, T. E., Hyman, B. T., & Bacskai, B. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-19 · Cited by 72
Self-citationEarly Stages for Parkinson’s Development: α-Synuclein Misfolding and Aggregation
Yu, J., & Lyubchenko, Y. L. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9115-5 · Cited by 75
Sorensen, E. W., Lian, J., Ozga, A. J., Miyabe, Y., Ji, S., Bromley, S. K., Mempel, T. R., & Luster, A. D. (2018) · JCI Insight · doi:10.1172/jci.insight.98911 · Cited by 75
Tian, X., Zhang, L., Wang, J., Dai, J., Shen, S., Yang, L., & Huang, P. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.026 · Cited by 73
Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 76
Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system
Vickers, J. C., King, A. E., Woodhouse, A., Kirkcaldie, M. T., Staal, J. A., McCormack, G. H., Blizzard, C. A., Musgrove, R. E. J., Mitew, S., Liu, Y., et al. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.004 · Cited by 69
Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review
Liao, H., Zhu, Z., & Peng, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00188 · Cited by 74
Regulation of amyloid precursor protein processing by its KFERQ motif
Park, J.-S., Kim, D.-H., & Yoon, S.-Y. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.6.212 · Cited by 69
“Extracellular accumulation of amyloid- (A) in senile plaques is a key pathological finding in AD and is regarded as the primary causative factor of neurodegeneration (1, 2).”
BackgroundRamos‐Rodríguez, J. J., Jiménez-Palomares, M., Murillo-Carretero, M. I., Infante‐Garcia, C., Berrocoso, E., Pacho, F. H., Lechuga-Sancho, A. M., Cózar‐Castellano, I., & García-Alloza, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.606 · Cited by 72
Development of the microglial phenotype in culture
Szabó, M., & Gulya, K. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.033 · Cited by 72
The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives
Rosmus, D.-D., Lange, C., Ludwig, F., Ajami, B., & Wieghofer, P. (2022) · Biomedicines · doi:10.3390/biomedicines10040840 · Cited by 67
“Histopathological studies indicate that microglia form clusters around amyloid plaques in mouse models of AD and in AD patients [123,124] (Figure 3B).”
BackgroundATP and NO dually control migration of microglia to nerve lesions
Duan, Y., Sahley, C. L., & Muller, K. J. (2009) · Developmental Neurobiology · doi:10.1002/dneu.20689 · Cited by 67
“Those signals may involve diverse molecules, some of which are released at lesions and are thought to be chemoattractant for microglia (Honda et al., 2001; Haynes et al., 2006; Meyer-Luehmann et al., 2008).”
BackgroundMicroglial toll-like receptors and Alzheimer’s disease
Su, F., Bai, F., Zhou, H., & Zhang, Z. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.10.010 · Cited by 71
Paulson, J. B., Ramsden, M., Forster, C. L., Sherman, M. A., McGowan, E. M., & Ashe, K. H. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080175 · Cited by 75
Košak, U., Knez, D., Coquelle, N., Brus, B., Pišlar, A. H., Nachon, F., Brazzolotto, X., Kos, J., Colletier, J., & Gobec, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.032 · Cited by 67
Jackson, H. M., Soto, I., Graham, L. C., Carter, G. W., & Howell, G. R. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-831 · Cited by 66
Amyloid and Alzheimer's Disease: Inside and Out
Tam, J. H. K., & Pasternak, S. H. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013408 · Cited by 66
Madhu, L. N., Kodali, M., Upadhya, R., Rao, S., Somayaji, Y., Attaluri, S., Shuai, B., Kirmani, M., Gupta, S., Maness, N., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12519 · Cited by 79
“In both AD models and patients, A β plaques increase progressively and are surrounded by activated microglia with DAM genes signature and an impaired ability for phagocytosis and A β clearance (Hickman et al., 2008; Meyer-Luehmann et al., 2008).”
BackgroundAntibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy
Liu, J., Yang, B., Ke, J., Li, W., & Suen, W.-C. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0406-x · Cited by 74
“Soluble Ab oligomers acting as a reservoir of toxic Ab assemblies in the pathological process of AD [32] can bring about cognitive deterioration and synaptic malfunction [33].”
BackgroundPushing the Boundaries of Neuroimaging with Optoacoustics
Ovsepian, S. V., Olefir, I., Westmeyer, G. G., Razansky, D., & Ntziachristos, V. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.022 · Cited by 69
Four Decades of Neurodegenerative Disease Research: How Far We Have Come!
Young, A. B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3767-09.2009 · Cited by 72
“Furthermore, new data, obtained by multiphoton microscopy and other techniques, have shown that turnover of many culprit proteins is rapid—rather than slow (Meyer-Luehmann et al., 2008; Spires-Jones et al., 2009b).”
BackgroundMethodMetallosupramolecular complex targeting an α/β discordant stretch of amyloid β peptide
Yu, H., Li, M., Liu, G., Geng, J., Wang, J., Ren, J., Zhao, C., & Qu, X. (2012) · Chemical Science · doi:10.1039/c2sc20372c · Cited by 69
Infante‐Garcia, C., Ramos‐Rodríguez, J. J., Galindo-Gonzalez, L., & García-Alloza, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.12.001 · Cited by 71
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67
“In AD mice models this recruitment can occur as quickly as within a day of plaque formation and results in a two-fivefold increase in microglia at Aβ plaques compared to the neighboring tissue (Frautschy et al., 1998; Simard et al., 2006; Meyer-Luehmann et al., 2008).”
BackgroundHuang, W.-C., Yen, F.-C., Shie, F.-S., Pan, C.-M., Shiao, Y.-J., Yang, C.-N., Huang, F.-L., Sung, Y.-J., & Tsay, H.-J. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-28 · Cited by 64
An Imaging and Systems Modeling Approach to Fibril Breakage Enables Prediction of Amyloid Behavior
Xue, W.-F., & Radford, S. E. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.10.034 · Cited by 64
Ramos‐Rodríguez, J. J., Spires‐Jones, T. L., Pooler, A. M., Lechuga-Sancho, A. M., Bacskai, B. J., & García-Alloza, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9921-3 · Cited by 71
Self-citationPark, M.-C., Hoang, G. M., Nguyen, T. H., Lee, E., Jung, H. J., Choe, Y., Lee, M. H., Hwang, J. Y., Kim, J. G., & Kim, T. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00274-x · Cited by 69
“The brillar plaques also causally related to the progressive neuritic abnormalities in amyloid precursor protein (APP) transgenic mice model [33, 34].”
BackgroundTFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications
Gu, Z., Cao, H., Zuo, C., Huang, Y., Miao, J., Song, Y., Yang, Y., Zhu, L., & Wang, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105855 · Cited by 71
Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer’s Disease
Wang, Q., Sun, J., Chen, T., Song, S., Hou, Y., Feng, L., Fan, C., & Li, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00343 · Cited by 69
Gallagher, J. J., Finnegan, M. E., Grehan, B., Dobson, J., Collingwood, J. F., & Lynch, M. A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110614 · Cited by 63
“cytosis of plaques occurs [20].”
Caspases as therapeutic targets in Alzheimer's disease: is it time to "cut" to the chase?
Rohn, T. T., & Head, E. (2009) · PubMed Central · Cited by 63
Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases
Walker, L. C. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034943 · Cited by 63
“Studies in animal models show that Aβ plaques themselves have cytotoxic properties (94; 105), but, as in the case of many amyloidogenic proteins, Aβ also forms small, soluble, oligomeric assemblies that contribute to neuronal dysfunction and death (34; 48; 84).”
BackgroundUnni, V. K., Weissman, T. A., Rockenstein, E., Masliah, E., McLean, P. J., & Hyman, B. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010589 · Cited by 62
“multiphoton imaging techniques in mouse models. New insights into the mechanisms of AD involving the formation of extracellular beta-amyloid plaques”
BackgroundSelf-citationMeyer-Luehmann, M., Mielke, M., Spires-Jones, T. L., Stoothoff, W., Jones, P., Bacskai, B. J., & Hyman, B. T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1948-09.2009 · Cited by 62
“In contrast, plaques are associated with inflammatory responses, neuronal morphological alterations, and disturbances in local calcium homeostasis (D’Amore et al., 2003; Spires et al., 2005; Busche et al., 2008; Kuchibhotla et al., 2008; Meyer-Luehmann et al., 2008).”
Self-citationMa, B., Day, J., Phillips, H., Slootsky, B., Tolosano, E., & Doré, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0490-1 · Cited by 66
Fernandez-Valenzuela, J. J., Sanchez-Varo, R., Muñoz-Castro, C., De Castro, V., Sanchez-Mejias, E., Navarro, V., Jimenez, S., Nuñez-Diaz, C., Gomez-Arboledas, A., Moreno-Gonzalez, I., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71767-4 · Cited by 61
Mishra, P., Silva, A., Sharma, J., Nguyen, J., Pizzo, D. P., Hinz, D., Sahoo, D., & Cherqui, S. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112956 · Cited by 65
Alkhalifa, A. E., Mokhlf, A. A., Ali, H., Al-Ghraiybah, N. F., & Syropoulou, V. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15090437 · Cited by 77
Inflammation and Microglia Actions in Alzheimer’s Disease
Combs, C. K. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9165-3 · Cited by 71
Wang, X.-P., Zhang, J.-H., Wang, Y.-J., Feng, Y., Zhang, X., Sun, X.-X., Li, J.-L., Du, X.-T., Lambert, M. P., Yang, S.-G., et al. (2009) · FEBS Letters · doi:10.1016/j.febslet.2008.12.064 · Cited by 61
Stone, J. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.04.007 · Cited by 67
“[53] Meyer-Luehmann M, Spires-Jones TL, Prada C, GarciaAlloza M, de Calignon A, Rozkalne A, et al.”
Alzheimer‘s Disease and Epilepsy: Insight From Animal Models
Scharfman, H. E. (2012) · Future Neurology · doi:10.2217/fnl.12.8 · Cited by 59
“Instead, a gradual accumulation of A emerges, although there is some evidence for periods of rapid accumulation of A [40].”
BackgroundPrediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice
Ramos‐Rodríguez, J. J., Ortiz-Barajas, O., Gamero-Carrasco, C., de la Rosa, P. R., Infante‐Garcia, C., Zopeque-Garcia, N., Lechuga-Sancho, A. M., & García-Alloza, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.005 · Cited by 64
Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
Ghosh, S., & Geahlen, R. L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.09.053 · Cited by 59
“they also become activated as a consequence of receptor engagement by Aβ (7-9).”
BackgroundMethodResultInfluentialIn vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques
Burgold, S., Filser, S., Dorostkar, M. M., Schmidt, B., & Herms, J. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-30 · Cited by 59
“Furthermore, two studies found no steady plaque growth [17,19,21] or plaque growth and shrinkage [33] in the early phase of plaque development.”
BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer’s disease
Burke, R. M., Norman, T. A., Haydar, T. F., Slack, B. E., Leeman, S. E., Blusztajn, J. K., & Mellott, T. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319297110 · Cited by 59
Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction
Gireud, M., Mack, A. F., McCullough, L. D., & Urayama, A. (2020) · The Neuroscientist · doi:10.1177/1073858420954811 · Cited by 72
Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease
Tsering, W., & Prokop, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03736-7 · Cited by 59
Brown, L. A. M., Jin, J., Ferrell, D., Sadic, E., Obregon, D., Smith, A. J., Tan, J., & Giunta, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095500 · Cited by 59
Kell, D. B., & Pretorius, E. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1604108 · Cited by 71
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy
La Rosa, F., Saresella, M., Marventano, I., Piancone, F., Ripamonti, E., Al-Daghri, N., Bazzini, C., Zoia, C. P., Conti, E., Ferrarese, C., et al. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181259 · Cited by 59
Myeloid cells in Alzheimer’s disease: culprits, victims or innocent bystanders?
Meyer-Luehmann, M., & Prinz, M. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.011 · Cited by 55
Self-citationTherapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
Calvo-Rodríguez, M., Kharitonova, E. K., & Bacskai, B. J. (2020) · Cells · doi:10.3390/cells9112513 · Cited by 68
Self-citationA two-photon fluorescent probe for amyloid-β plaques in living mice
Heo, C. H., Kim, K. H., Kim, H. J., Baik, S. H., Song, H., Kim, Y. S., Lee, J., Mook‐Jung, I., & Kim, H. M. (2012) · Chemical Communications · doi:10.1039/c2cc38570h · Cited by 58
Alzheimers Disease: Pathological Mechanisms and Recent Insights
Niedowicz, D. M., Nelson, P. T., & Murphy, M. P. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376181 · Cited by 74
“Mouse models have also been used to study the near real-time deposition of amyloid in the brain [82].”
Genetic manipulation of microglia during brain development and disease
Wieghofer, P., & Prinz, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.019 · Cited by 62
Lau, H. H. C., Ingelsson, M., & Watts, J. C. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02201-2 · Cited by 63
Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases
Lima, M. N., Barbosa‐Silva, M. C., & Maron‐Gutierrez, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.878987 · Cited by 71
Jendresen, C. B., Cui, H., Zhang, X., Vlodavsky, I., Nilsson, L. N. G., & Li, J.-P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600569 · Cited by 57
“Two-photon laser-scanning intravital microscopy (32) or seeding experiments (33) are needed to provide final in vivo proof that the aggregation process is indeed impaired in tgHpa*Swe mice.”
Background
Metadata
- Authors
- Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7179
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3264491
- OpenAlex
- W2107015337
- Cited by
- 987
- References
- 27
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 45 · 2023: 38 · 2022: 45 · 2021: 56 · 2020: 43 · 2019: 40 · 2018: 37 · 2017: 36 · 2016: 57 · 2015: 51 · 2014: 48 · 2013: 62 · 2012: 83
- FWCI
- 66.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R01AG008487, P50AG005134, P30AG062421)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid plaques, microglial activation, microglial recruitment, APP/PS1 mice, amyloid hypothesis, cortical degeneration
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Transgenic, Time Factors, Amyloid beta-Peptides, Neurites, Microglia, Disease Progression, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.